Sources Contact Advanced Search Tutorials

An Interest In:

Web News this Week

Search Archive

Some of Our Sources

View All Sources

Help Webnuz

Referal links:

May 22, 2020 07:00 am

US Secures 300 Million Doses, Almost a Third, of Potential AstraZeneca COVID-19 Vaccine

schwit1 shares a report from Financial Post: The United States has secured almost a third of the first one billion doses planned for AstraZeneca's experimental COVID-19 vaccine by pledging up to $1.2 billion, as world powers scramble for medicines to get their economies back to work. While not proven to be effective against the coronavirus, vaccines are seen by world leaders as the only real way to restart their stalled economies, and even to get an edge over global competitors. The U.S. Department of Health agreed to provide up to $1.2 billion to accelerate AstraZeneca's vaccine development and secure 300 million doses for the United States. "This contract with AstraZeneca is a major milestone in Operation Warp Speed's work toward a safe, effective, widely available vaccine by 2021," U.S. Health Secretary Alex Azar said. The vaccine, previously known as ChAdOx1 nCoV-19 and now as AZD1222, was developed by the University of Oxford and licensed to British drugmaker AstraZeneca. Immunity to the new coronavirus is uncertain and so the use of vaccines unclear. The U.S. deal allows a late-stage -- Phase III -- clinical trial of the vaccine with 30,000 people in the United States.

Slashdot

Slashdot was originally created in September of 1997 by Rob "CmdrTaco" Malda. Today it is owned by Geeknet, Inc..

More About this Source Visit Slashdot